AYLA - Ayala Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Ayala Pharmaceuticals's activity chart (see below) currently has 15 price targets and 21 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 25.64% of the time, taking 28.92 days on average.

Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 31-Oct-2022. First documented stock forecast 02-Jun-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 31-Oct-2022

$16

4 years 21 days ago
(31-Oct-2022)

0/1 (0%)

$12 (300.00%)

Buy Since 07-Dec-2020

$0.55

4 years 1 months 1 days ago
(20-Oct-2022)

2/2 (100%)

$-0.13 (-19.12%)

50

Buy Since 21-Dec-2021

$18

4 years 3 months 5 days ago
(16-Aug-2022)

0/2 (0%)

$9.25 (105.71%)

Buy Since 10-Jun-2020

$6

4 years 7 months 22 days ago
(30-Mar-2022)

0/2 (0%)

$2.05 (51.90%)

Buy Since 21-Dec-2021

$12

$18

4 years 7 months 22 days ago
(30-Mar-2022)

0/3 (0%)

$8 (200.00%)

Show more analysts

Please expand the browser size to see the chart

What is AYLA (Ayala Pharmaceuticals) average time for price targets to be met?

On average it took 29 days for the stock forecasts to be reached, with an average price target met ratio of 25.64%.

Which analyst most recently updated their price target on AYLA (Ayala Pharmaceuticals)?

Jay Olson

Which analyst has the most public recommendations on AYLA (Ayala Pharmaceuticals)?

Jay Olson works at OPPENHEIMER and has 6 price targets and 4 ratings on AYLA

Which analyst is the currently most bullish on AYLA (Ayala Pharmaceuticals)?

Ahu Demir with the highest potential upside of $28.5

Which analyst is the currently most reserved on AYLA (Ayala Pharmaceuticals)?

Maury Raycroft with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?